Benefits
Skin brightening / more even tone (manufacturer trial)
Mibelle reports a double-blind, placebo-controlled trial in women in which 150 mg/day for 12 weeks increased skin lightness (L*) and individual typology angle. This trial is not PubMed-indexed, so treat as manufacturer evidence.
Inhibits excess pigment formation
In laboratory models, apple mint flavonoids inhibit melanogenesis (melanin production), the proposed basis for a brightening, even-tone effect taken from within.
Antioxidant defense support
The extract raises antioxidant enzyme activity (e.g., SOD3) in models, consistent with general skin antioxidant support.
Mechanism of action
Melanogenesis inhibition
Apple mint flavonoids downregulate steps in melanin synthesis, which over time can reduce excess pigmentation and even skin tone.
Antioxidant enzyme upregulation
Increased SOD3 and related antioxidant defenses help protect skin from oxidative, UV-related stress that drives uneven pigmentation.
Clinical trials
Double-blind, randomized, placebo-controlled, 150 mg/day for 12 weeks (registered as a clinical trial). Published in a non-PubMed-indexed journal.
Around 100 women
Increased skin lightness (L*) and individual typology angle versus placebo. Treat as manufacturer evidence pending indexed publication.